Arrowhead Pharmaceuticals, Inc.

Bank of New York Mellon Corp ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

887,848

Value ($000)

58,944

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	58,944	0.0%	887,848	12/31/2025
2025 Q3	11/3/2025	28,094	0.0%	814,548	9/30/2025
2025 Q2	8/5/2025	12,926	0.0%	818,079	6/30/2025
2025 Q1	4/29/2025	9,887	0.0%	776,039	3/31/2025
2024 Q4	2/4/2025	15,605	0.0%	830,058	12/31/2024
2024 Q3	11/12/2024	16,782	0.0%	866,399	9/30/2024
2024 Q2	7/25/2024	28,201	0.0%	1,085,069	6/30/2024
2024 Q1	4/25/2024	30,173	0.0%	1,054,983	3/31/2024
2023 Q4	1/29/2024	29,312	0.0%	957,906	12/31/2023
2023 Q3	10/24/2023	26,618	0.0%	990,628	9/30/2023
2023 Q2	8/3/2023	36,910	0.0%	1,035,064	6/30/2023
2023 Q1	5/9/2023	26,416	0.0%	1,039,993	3/31/2023
2022 Q4	2/14/2023	43,282	0.0%	1,067,109	12/31/2022
2022 Q3	11/14/2022	35,491	0.0%	1,073,815	9/30/2022
2022 Q2	8/15/2022	36,496	0.0%	1,036,572	6/30/2022
2022 Q1	5/11/2022	48,047	0.0%	1,044,740	3/31/2022
2021 Q4	2/11/2022	69,201	0.0%	1,043,751	12/31/2021
2021 Q3	11/18/2021	66,140	0.0%	1,059,433	9/30/2021
2021 Q2	8/11/2021	89,899	0.0%	1,085,471	6/30/2021
2021 Q1	5/13/2021	67,348	0.0%	1,015,636	3/31/2021
2020 Q4	2/9/2021	79,573	0.0%	1,037,071	12/31/2020
2020 Q3	11/12/2020	45,672	0.0%	1,060,671	9/30/2020
2020 Q2	8/12/2020	47,349	0.0%	1,096,297	6/30/2020
2020 Q1	5/6/2020	30,658	0.0%	1,065,598	3/31/2020
2019 Q4	2/14/2020	67,415	0.0%	1,062,801	12/31/2019